Cardiac Science Corporation [NASDAQ: CSCX] is initiating a worldwide voluntary recall after determining that approximately 12,200 automated external defibrillators (AEDs) may not be able to deliver therapy during a resuscitation attempt, which may lead to serious adverse events or death. These AEDs were manufactured in a way that makes them potentially susceptible to failure under certain conditions. The FDA has been informed of this situation.
Creating memories for families by sharing information relating to children and parents with regard to activities, products, school, home and more.
Cardiac Science Notifies AED Customers of Voluntary Medical Device Recall
- Login or register to post comments
- Feed: Food and Drug Administration--Recalls
- Original article